Literature DB >> 10386695

Acute complications in the current era of therapeutic cardiac catheterization for congenital heart disease.

B Zeevi1, M Berant, R Fogelman, B M Galit, L C Blieden.   

Abstract

The acute complications of therapeutic cardiac catheterization for congenital heart disease as performed currently in a small unit were reviewed. In recent years, there has been a significant increase in the number of lesions thought amenable to catheter therapy. Only a few reports, however, have addressed the overall incidence of acute complications of therapeutic cardiac catheterization, all representing the experience of centres performing moderate-to-large numbers of procedures. A retrospective review was performed of 425 therapeutic catheter procedures performed at our institution between May 1993 and November 1997. Acute complications were retrieved from the database. This included all adverse events that were clinically recognized at the time of or within 2 weeks after the procedure and which, to the best of the authors' clinical judgement, were related to the catheterization and not part of the natural history of the child's illness. All patients were observed overnight following the procedure, and stayed in hospital if a complication developed. There were 49 acute complications (11.5%), of which 43 (10.1%) were deemed minor and 6 (1.4%) were considered major. The rate was low in patients with valvar pulmonary stenosis, including three neonates (3/45, 6.7%), for those undergoing angioplasty of native co-arctation (1/15, 6.7%) and pulmonary arteries (2/27, 7.4%); and for coil embolization of systemic to pulmonary collateral arteries (1/16, 6.3%). The rate was high in patients with valvar aortic stenosis, including 12 neonates (9/37, 24.3%), and for angioplasty of re-coarctation (4/23, 21.7%). There were more overall complications in neonates (25.6%) than in older patients (10.1%) (p < 0.01). Two patients died (0.5%), but no patient required emergency surgical intervention. In spite of the introduction of many new therapeutic modalities with greater intrinsic risk, and the fact that patients with more complex lesions and who are more acutely ill are being treated, the overall rate of complications remains relatively low. This probably reflects improvements in pericatheterization medical management, in selection of patients, in procedural techniques, and in the experience of operators.

Entities:  

Mesh:

Year:  1999        PMID: 10386695     DOI: 10.1017/s1047951100004923

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  8 in total

1.  The role of cardiovascular magnetic resonance in candidates for Fontan operation: proposal of a new algorithm.

Authors:  Lamia Ait-Ali; Daniele De Marchi; Massimo Lombardi; Luigi Scebba; Eugenio Picano; Bruno Murzi; Pierluigi Festa
Journal:  J Cardiovasc Magn Reson       Date:  2011-11-11       Impact factor: 5.364

2.  What is the clinical utility of routine cardiac catheterization before a Fontan operation?

Authors:  Puja Banka; Doff B McElhinney; Emile A Bacha; John E Mayer; Kimberlee Gauvreau; Tal Geva; David W Brown
Journal:  Pediatr Cardiol       Date:  2010-05-26       Impact factor: 1.655

3.  Femoral arterial thrombosis after cardiac catheterization in infancy: impact of Doppler ultrasound for diagnosis.

Authors:  Walter Knirsch; Christian Kellenberger; Sven Dittrich; Peter Ewert; Martin Lewin; Reinald Motz; Jan Nürnberg; Oliver Kretschmar
Journal:  Pediatr Cardiol       Date:  2012-09-09       Impact factor: 1.655

4.  Contrast administration in pediatric cardiac catheterization: dose and adverse events.

Authors:  Selvi Senthilnathan; Kimberlee Gauvreau; Audrey C Marshall; James E Lock; Lisa Bergersen
Journal:  Catheter Cardiovasc Interv       Date:  2009-05-01       Impact factor: 2.692

5.  A risk adjusted method for comparing adverse outcomes among practitioners in pediatric and congenital cardiac catheterization.

Authors:  Lisa Bergersen; Kimberlee Gauvreau; James E Lock; Kathy J Jenkins
Journal:  Congenit Heart Dis       Date:  2008 Jul-Aug       Impact factor: 2.007

Review 6.  Cardiovascular magnetic resonance: Diagnostic utility and specific considerations in the pediatric population.

Authors:  Frances M Mitchell; Sanjay K Prasad; Gerald F Greil; Peter Drivas; Vassilios S Vassiliou; Claire E Raphael
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 7.  The role of cardiovascular magnetic resonance in pediatric congenital heart disease.

Authors:  Hopewell N Ntsinjana; Marina L Hughes; Andrew M Taylor
Journal:  J Cardiovasc Magn Reson       Date:  2011-09-21       Impact factor: 5.364

8.  Complications of Cardiac Catheterization in Structural Heart Disease.

Authors:  Ko Eun Lee; Yeon Jeong Seo; Gi Beom Kim; Hyo Soon An; Young Hwan Song; Bo Sang Kwon; Eun Jung Bae; Chung Il Noh
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.